Acute Lymphoblastic Leukemia

What is acute lymphoblastic leukemia?

Acute lymphoblastic leukemia (often shortened to ALL) is a cancer of the blood and bone marrow. Bone marrow is the soft, spongy tissue inside bones where new blood cells are made. In acute lymphoblastic leukemia, the bone marrow produces large numbers of immature white blood cells called lymphoblasts. These abnormal cells do not develop into healthy, infection-fighting white blood cells. Instead, they multiply quickly and crowd out the normal cells the body needs, including red blood cells (which carry oxygen), platelets (which help blood clot), and mature white blood cells (which fight infection).

The word “acute” means the disease develops and progresses quickly, often over days or weeks, rather than months or years. “Lymphoblastic” refers to the type of cell involved: the lymphoblast, an early form of a lymphocyte, which is one of the main types of white blood cells. Because the disease moves quickly, treatment usually needs to begin soon after diagnosis.

Acute lymphoblastic leukemia is the most common type of cancer in children, and most cases occur in young children. However, it can develop at any age, and it also affects teenagers and adults, including older adults. In children, ALL often responds well to treatment. In adults, the disease can be more challenging to treat, though many treatment options exist for all age groups.

There are two main subtypes, based on the type of lymphocyte affected: B-cell ALL, which is the more common form, and T-cell ALL. Doctors identify the subtype through laboratory testing, because it can influence which treatments are recommended.

Symptoms of acute lymphoblastic leukemia

Acute lymphoblastic leukemia symptoms appear because the abnormal cells crowd out healthy blood cells. Many of the symptoms are vague at first and can resemble common illnesses such as the flu, which is one reason the disease is sometimes not suspected right away. Unlike a passing infection, however, these symptoms tend to persist or worsen over time.

Common acute lymphoblastic leukemia symptoms include:

• Fatigue and weakness — caused by a shortage of red blood cells (anemia).
• Pale skin — another sign of anemia.
• Frequent or persistent infections and fever — because there are too few healthy white blood cells to fight germs.
• Easy bruising or bleeding — including frequent nosebleeds, bleeding gums, or tiny red or purple spots on the skin (called petechiae), caused by low platelet counts.
• Bone or joint pain — because the bone marrow becomes crowded with abnormal cells.
• Swollen lymph nodes — painless lumps in the neck, armpits, or groin.
• Loss of appetite and unintended weight loss.
• Shortness of breath — often related to anemia, or in some cases to a mass in the chest.
• Night sweats.
• A feeling of fullness or discomfort in the abdomen — which can occur if the spleen or liver becomes enlarged.

Symptoms can differ somewhat by subtype and by how far the disease has spread. T-cell ALL, for example, sometimes causes a mass of cells in the chest (in an area called the mediastinum, the space between the lungs), which can lead to coughing, breathing difficulty, or swelling of the face and arms. If leukemia cells spread to the fluid around the brain and spinal cord, symptoms may include headaches, vomiting, blurred vision, or, less commonly, seizures. In males, the disease occasionally involves the testicles, causing painless swelling.

Because acute lymphoblastic leukemia develops quickly, symptoms often appear over a short period. Anyone with a combination of persistent fatigue, unexplained bruising or bleeding, ongoing fevers, and bone pain should be evaluated by a doctor promptly.

Causes and risk factors

In most cases, doctors cannot identify a specific cause for an individual person’s leukemia. What is known is that acute lymphoblastic leukemia causes involve changes (mutations) in the DNA of developing blood cells in the bone marrow. DNA is the genetic material that tells cells how to grow and behave. When certain mutations occur, a cell can begin to multiply out of control and fail to mature properly. These genetic changes are usually acquired during a person’s lifetime rather than inherited, and they are generally not something the person or their parents could have prevented.

Although the exact trigger is usually unknown, research has identified factors that can increase the risk of developing ALL:

• Age — the disease is most common in young children, with a second, smaller rise in risk in older adults.
• Previous cancer treatment — some types of chemotherapy and radiation therapy given for other cancers can raise the risk of later developing leukemia.
• Exposure to high doses of radiation — for example, survivors of nuclear accidents have a higher risk.
• Certain genetic conditions — inherited disorders such as Down syndrome are associated with an increased risk of childhood leukemia.
• Exposure to certain chemicals — long-term exposure to benzene, an industrial chemical, has been linked to leukemia, though this association is more established for other leukemia types.
• Family history — having a sibling with ALL slightly increases risk, although most people with a family history never develop the disease.

It is important to understand that most people with one or more risk factors never develop acute lymphoblastic leukemia, and many people who develop it have no known risk factors at all. ALL is not contagious, and it is not caused by everyday lifestyle choices in any proven way.

Diagnosis

Acute lymphoblastic leukemia diagnosis begins when a doctor suspects a blood problem based on symptoms or a routine blood test. Confirming the diagnosis requires laboratory examination of blood and bone marrow, because doctors need to see the abnormal cells directly and study their features.

Blood tests

The first step is usually a complete blood count (CBC), a common blood test that measures the numbers of red blood cells, white blood cells, and platelets. In ALL, the results are often abnormal: red blood cell and platelet counts may be low, and the white blood cell count may be very high or, in some cases, low. A laboratory specialist may also examine a blood smear, a sample of blood spread on a slide and viewed under a microscope, to look for lymphoblasts.

Bone marrow tests

The definitive test is a bone marrow aspiration and biopsy. In this procedure, a doctor uses a needle to remove a small sample of liquid marrow (aspiration) and a small core of bone and marrow tissue (biopsy), usually from the hip bone. The area is numbed with local anesthetic, and sedation may be used, especially for children. A diagnosis of ALL is typically confirmed when a significant proportion of the cells in the bone marrow are lymphoblasts.

Specialized laboratory testing

Once leukemia cells are found, laboratories perform additional tests to characterize them precisely. These include immunophenotyping (a test that identifies proteins on the surface of the cells to determine whether they are B-cell or T-cell type) and genetic tests (which look for specific chromosome changes and gene mutations in the leukemia cells). One important example is testing for the Philadelphia chromosome, a specific genetic abnormality that affects treatment choices. These results help doctors classify the disease and predict how it may respond to different therapies.

Lumbar puncture

Because ALL can spread to the central nervous system (the brain and spinal cord), doctors usually perform a lumbar puncture, also called a spinal tap. A thin needle is inserted into the lower back to collect a small sample of cerebrospinal fluid, the fluid that surrounds the brain and spinal cord, which is then checked for leukemia cells.

Imaging

Imaging tests do not diagnose leukemia by themselves, but they help doctors assess how the disease is affecting the body. A chest X-ray may be done to look for a mass in the chest, and ultrasound or computed tomography (CT) scans can evaluate enlarged organs or lymph nodes. In selected situations, doctors may use advanced imaging such as PET-CT imaging, which combines a metabolic scan with a CT scan, to evaluate disease involvement outside the bone marrow.

Treatment options

Acute lymphoblastic leukemia treatment usually starts soon after diagnosis, because the disease progresses quickly. Unlike some slow-growing blood cancers, watchful waiting (monitoring without immediate treatment) is generally not appropriate for ALL. Treatment plans are individualized based on the patient’s age, overall health, the subtype of leukemia, and the genetic features of the leukemia cells. Care is typically coordinated by hematologists and oncologists, doctors who specialize in blood disorders and cancer; within the Acibadem network, this condition is managed through the Medical Oncology Department and its hematology teams, with children cared for by specialists in pediatric oncology.

Chemotherapy

Chemotherapy, medication that kills fast-growing cells, is the foundation of treatment for ALL. It is usually given in phases over an extended period, often lasting two years or more in total:

• Induction — the first, intensive phase, aimed at destroying as many leukemia cells as possible and restoring normal blood cell production. The goal is remission, meaning no leukemia cells can be detected by standard tests.
• Consolidation (intensification) — additional treatment given after remission to eliminate any remaining leukemia cells that cannot be seen.
• Maintenance — lower-dose treatment given over a longer period to reduce the chance of the disease returning.

Because ALL can hide in the central nervous system, most treatment plans include medication given directly into the spinal fluid (called intrathecal chemotherapy) to prevent or treat disease in that area.

Targeted therapy

Targeted therapies are medications designed to attack specific abnormalities in cancer cells. For patients whose leukemia cells carry the Philadelphia chromosome, drugs called tyrosine kinase inhibitors are typically added to chemotherapy. These medicines block the abnormal protein that drives the growth of those leukemia cells.

Immunotherapy and CAR-T cell therapy

Immunotherapy uses the body’s own immune system to fight cancer. Several antibody-based drugs are now used for certain types of B-cell ALL, particularly when the disease has not responded to initial treatment or has returned. One advanced form of immunotherapy is CAR-T cell therapy, in which a patient’s own immune cells (T cells) are collected, modified in a laboratory so they can recognize and attack leukemia cells, and then returned to the patient. It is used in selected cases of relapsed or treatment-resistant B-cell ALL and requires care at specialized centers.

Stem cell transplantation

A stem cell transplant (also called a bone marrow transplant) replaces a patient’s diseased bone marrow with healthy blood-forming stem cells, usually from a donor. It may be recommended for patients whose disease has high-risk features or has come back after initial treatment. Transplantation is an intensive procedure with significant risks, and the decision depends on many individual factors that patients discuss in detail with their care team.

Radiation therapy

Radiation therapy, which uses high-energy beams to destroy cancer cells, is used less often than in the past, but it may still play a role in specific situations, such as treating leukemia that has spread to the brain, or as part of preparation for a stem cell transplant.

Surgery and supportive care

Surgery is not used to treat ALL itself, because the disease is spread throughout the blood and bone marrow rather than located in a single tumor. Minor surgical procedures are common, however, such as placing a central venous catheter or port (a small device under the skin) to make it easier to give medication and take blood samples. Supportive care is an essential part of treatment and may include blood and platelet transfusions, antibiotics to prevent or treat infections, and medications to manage side effects. Comprehensive programs for leukemia and lymphoma treatment combine these therapies within a coordinated plan tailored to each patient.

Living with acute lymphoblastic leukemia and outlook

The outlook for people with acute lymphoblastic leukemia varies widely and depends on many factors, including age, the subtype of the disease, the genetic features of the leukemia cells, and how well the disease responds to initial treatment. In general, children tend to respond very well to modern treatment, and many are cured. Outcomes in adults have improved over time with newer therapies, though the disease is often harder to treat in older patients. No doctor can promise a specific outcome for an individual patient, and it is reasonable to ask your own care team what the findings in your case suggest.

Treatment for ALL is long and demanding. Patients often spend time in the hospital during intensive phases and need frequent clinic visits during maintenance. Common challenges include fatigue, increased vulnerability to infection, changes in appetite, hair loss during chemotherapy, and emotional strain. Practical steps that many patients find helpful include:

• Following infection-prevention advice carefully, such as hand hygiene and avoiding sick contacts, especially when blood counts are low.
• Attending all follow-up appointments, since regular blood tests and, at times, bone marrow tests are used to monitor remission.
• Discussing fertility preservation options before treatment begins, when relevant, as some therapies can affect fertility.
• Seeking psychological support for patients and family members; a leukemia diagnosis affects the whole household, and counseling or support groups can help.
• For children, working with schools and care teams to manage education during and after treatment.

After treatment ends, follow-up continues for years. Doctors monitor for any sign of the disease returning (relapse) and for late effects of treatment, such as effects on the heart, bones, growth in children, or the risk of other health conditions. Survivorship care plans help patients and their primary doctors keep track of recommended checks over the long term.

Frequently asked questions

What is acute lymphoblastic leukemia in simple terms?

It is a fast-growing cancer of the blood and bone marrow. The bone marrow makes too many immature white blood cells, called lymphoblasts, which crowd out the healthy cells the body needs to carry oxygen, stop bleeding, and fight infection. Because it develops quickly, treatment usually starts soon after diagnosis.

Can acute lymphoblastic leukemia be cured?

In many cases, yes, particularly in children, where modern treatment leads to long-term remission and cure for a large proportion of patients. In adults, cure is also possible, though the disease can be more difficult to treat, especially at older ages. The chance of cure depends on individual factors such as age, disease subtype, genetic features of the leukemia cells, and response to initial treatment, so it is best to discuss your specific situation with your care team.

How serious is acute lymphoblastic leukemia?

It is a serious condition that is life-threatening without treatment, because the shortage of healthy blood cells leads to severe anemia, bleeding, and infections. With prompt, appropriate treatment, however, many patients achieve remission, and long-term survival is common, especially in children. The seriousness in any individual case depends on how the disease responds to therapy.

What are the first symptoms of acute lymphoblastic leukemia?

Early symptoms are often vague and can resemble the flu: tiredness, pale skin, fever, and frequent infections. Easy bruising, unusual bleeding such as nosebleeds or bleeding gums, bone or joint pain, and swollen lymph nodes are also common. Because these symptoms have many possible causes, only medical testing can determine whether leukemia is responsible.

How is acute lymphoblastic leukemia diagnosed?

Doctors start with blood tests, including a complete blood count, which often shows abnormal cell counts. The diagnosis is confirmed with a bone marrow aspiration and biopsy, in which a small sample of marrow is examined under a microscope and tested in the laboratory to identify the type and genetic features of the leukemia cells. A lumbar puncture is usually done to check whether the disease has reached the fluid around the brain and spinal cord.

How long does treatment for acute lymphoblastic leukemia take?

Treatment is typically given in phases and often lasts two years or more in total, though the most intensive parts occur in the first months. The exact length depends on the treatment plan, the patient’s age, and how the disease responds. Some patients also undergo a stem cell transplant, which involves its own recovery period. Your care team can explain the expected timeline for your specific plan.

Does acute lymphoblastic leukemia come back after treatment?

In some patients, the disease returns after remission; this is called relapse. The risk varies with the features of the disease and how completely it responded to initial therapy, which is why regular follow-up with blood tests continues for years after treatment. If relapse occurs, further options may include additional chemotherapy, immunotherapy, CAR-T cell therapy, or stem cell transplantation, depending on the individual case.

When to see a doctor

Anyone with persistent, unexplained symptoms such as ongoing fatigue, pale skin, repeated infections, easy bruising, or bone pain should see a doctor for evaluation. These symptoms have many possible causes, most of which are not leukemia, but they should not be ignored, especially when several occur together or worsen over time.

Seek urgent medical attention if you or your child experiences any of the following red-flag warning signs:

• High or persistent fever, especially during cancer treatment, when infections can become dangerous quickly.
• Bleeding that will not stop, including heavy nosebleeds, blood in the urine or stool, or bleeding gums.
• Widespread bruising or a rash of tiny red or purple spots (petechiae) appearing suddenly.
• Severe shortness of breath, chest pain, or swelling of the face and neck.
• Severe headache, repeated vomiting, confusion, vision changes, or seizures.
• Extreme weakness, dizziness, or fainting.

For patients already receiving treatment for acute lymphoblastic leukemia, contact the treating care team immediately about any fever or signs of infection, even if symptoms seem mild, because a weakened immune system can allow infections to progress rapidly. Early evaluation and treatment can prevent serious complications.